[The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
Schwarz
S
S
Zentralinstitut für Seelische Gesundheit, 68167 Mannheim. stefan.schwarz@zi-mannheim.de
Frölich
L
L
Striebel
J-P
JP
Hennerici
M G
MG
D002986:Clinical Trials as Topic / Q000191:economics* / Q000331:legislation & jurisprudence*; D003132:Commerce; D003365:Costs and Cost Analysis; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D017041:Ethics Committees; D005380:Financing, Government; D005858:Germany; D019983:Guideline Adherence / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic; D012109:Research Support as Topic
D015507:Drugs, Investigational